Cell Lysis Market: Major Players and Growth Strategies
The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2020, at a CAGR 7.2% from 2021 to 2026. The growth of this market is driven by increasing government funding for research, high prevalence of diseases, and growing focus on personalized medicines.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321
The cell lysis market is highly consolidated and is dominated by various players. The major players operating in this market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), QIAGEN (Netherlands), Roche Diagnostics (Switzerland), Agilent Technologies Inc. (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), NZYTech Lda (Portugal), Labfreez Instruments Group Co., Limited (China), G-Biosciences (US), Covaris (US), Claremont BioSolutions LLC (US), Microfluidics International Corporation (US), Parr Instrument Company (US), BioVision Inc.(US), and Norgen Biotek (Canada).
Thermo Fisher Scientific (US)
Thermo
Fisher Scientifc (US) held the leading position in the cell lysis
market in 2020. Thermo Fisher offers an exhaustive product portfolio
consisting of various cell lysis products, such as reagents, kits, and
media. The company believes in both organic and inorganic growth for
enhancing its market position such collaboration, acquisition and
expansion. For instance, in 2020, Thermo Fisher Scientific entered
collaboration with Northeastern University To advance analytical
capabilities and accelerate innovation across the biopharmaceutical
industry in personalized medicine, monoclonal antibodies, and gene and
cell therapies. Furthermore, the company is innovation-centric and
invests heavily in R&D to maintain its market share..
Merck (Germany)
Merck
(Germany) accounted for the second-largest share of the global cell
lysis market in 2020. The company provides its radiation dowing to its
robust portfolio of cell lysis products and efforts to develop
innovative products by investing in R&D. To sustain its leading
position in the cell lysis market, the company pursues organic and
inorganic strategies such as expansion. For instance, in 2020, the
company expanded Life Science production facilities in Danvers,
Massachusetts, and Jaffrey, New Hampshire, US
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=260138321
North America accounted for the largest share of the cell lysis inudstry.
Based
on the region, the cell lysis market is segmented into North America,
Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North
America accounted for the largest share of the global market. The large
share of North America can be attributed to factors such as growing stem
cell and cancer research activities and the expanding biotechnology
& pharmaceutical industries
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment